Log in
Enquire now
‌

US Patent 9908845 Aryl ethers and uses thereof

Patent 9908845 was granted and assigned to Peloton Therapeutics on March, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Peloton Therapeutics
Peloton Therapeutics
0
Current Assignee
Peloton Therapeutics
Peloton Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99088450
Patent Inventor Names
Darryl David Dixon0
Bin Wang0
Paul Wehn0
Rui Xu0
Stephen T. Schlachter0
Eli M. Wallace0
Hanbiao Yang0
James P. Rizzi0
...
Date of Patent
March 6, 2018
0
Patent Application Number
149057760
Date Filed
September 5, 2014
0
Patent Citations Received
‌
US Patent RE49948 Aryl ethers and uses thereof
0
‌
US Patent 12077506 Indane derivatives as hypoxia inducible factor-2(α) inhibitors
0
‌
US Patent 11753366 Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
Patent Primary Examiner
‌
Theodore R West
0
Patent abstract

The present disclosure relates to HIF-2α inhibitors and methods of making and using them for treating cancer. Certain compounds were potent in HIF-2α scintillation proximity assay, luciferase assay, and VEGF ELISA assay, and led to tumor size reduction and regression in 786-O xenograft bearing mice in vivo.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9908845 Aryl ethers and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.